Donald G. Payan
2009
In 2009, Donald G. Payan earned a total compensation of $1.5M as Executive Vice President, President of Discovery and Research at Rigel Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $338,100 |
|---|---|
| Option Awards | $679,731 |
| Salary | $483,000 |
| Other | $3,564 |
| Total | $1,504,395 |
Payan received $679.7K in option awards, accounting for 45% of the total pay in 2009.
Payan also received $338.1K in non-equity incentive plan, $483K in salary and $3.6K in other compensation.
Rankings
In 2009, Donald G. Payan's compensation ranked 3,179th out of 9,885 executives tracked by ExecPay. In other words, Payan earned more than 67.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,179 out of 9,885 | 68th |
Division Manufacturing | 1,110 out of 3,690 | 70th |
Major group Chemicals And Allied Products | 218 out of 866 | 75th |
Industry group Drugs | 128 out of 638 | 80th |
Industry Pharmaceutical Preparations | 104 out of 446 | 77th |
Source: SEC filing on April 12, 2012.
Payan's colleagues
We found four more compensation records of executives who worked with Donald G. Payan at Rigel Pharmaceuticals in 2009.